1. Home
  2. SYT vs DRRX Comparison

SYT vs DRRX Comparison

Compare SYT & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYT
  • DRRX
  • Stock Information
  • Founded
  • SYT 2010
  • DRRX 1998
  • Country
  • SYT Japan
  • DRRX United States
  • Employees
  • SYT N/A
  • DRRX N/A
  • Industry
  • SYT Real Estate
  • DRRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SYT Finance
  • DRRX Health Care
  • Exchange
  • SYT Nasdaq
  • DRRX Nasdaq
  • Market Cap
  • SYT 40.2M
  • DRRX 44.4M
  • IPO Year
  • SYT 2023
  • DRRX 2000
  • Fundamental
  • Price
  • SYT $1.63
  • DRRX $0.85
  • Analyst Decision
  • SYT
  • DRRX Buy
  • Analyst Count
  • SYT 0
  • DRRX 2
  • Target Price
  • SYT N/A
  • DRRX $5.00
  • AVG Volume (30 Days)
  • SYT 23.6K
  • DRRX 124.3K
  • Earning Date
  • SYT 09-27-2024
  • DRRX 11-13-2024
  • Dividend Yield
  • SYT 0.43%
  • DRRX N/A
  • EPS Growth
  • SYT N/A
  • DRRX N/A
  • EPS
  • SYT 0.08
  • DRRX N/A
  • Revenue
  • SYT $149,124,408.00
  • DRRX $8,594,000.00
  • Revenue This Year
  • SYT N/A
  • DRRX $54.32
  • Revenue Next Year
  • SYT N/A
  • DRRX N/A
  • P/E Ratio
  • SYT $20.56
  • DRRX N/A
  • Revenue Growth
  • SYT 3.11
  • DRRX N/A
  • 52 Week Low
  • SYT $1.43
  • DRRX $0.48
  • 52 Week High
  • SYT $8.74
  • DRRX $1.88
  • Technical
  • Relative Strength Index (RSI)
  • SYT 57.39
  • DRRX 42.97
  • Support Level
  • SYT $1.56
  • DRRX $0.72
  • Resistance Level
  • SYT $1.79
  • DRRX $0.83
  • Average True Range (ATR)
  • SYT 0.16
  • DRRX 0.08
  • MACD
  • SYT 0.01
  • DRRX 0.02
  • Stochastic Oscillator
  • SYT 57.82
  • DRRX 52.40

About SYT SYLA Technologies Co. Ltd.

SYLA Technologies Co Ltd is a property technology company. It provides asset management platform systems that facilitate real estate crowd-funding as well as the purchase and sale of real estate.

About DRRX DURECT Corporation

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .

Share on Social Networks: